SHR-3032

N/A

Report date: 2023/09/12 16:44:34

Base Information

Drug NameSHR-3032
Drug Alias NameSHR-3032SHR3032
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantationGraft Rejection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangdong Hengrui Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGuangdong Hengrui Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationGraft Rejection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A